MYL Stock: Mind the Gap Mylan N.V. (NASDAQ: MYL) stock is rocketing higher on the heels of a U.S. Food and Drug Administration (FDA) approval of its glatiramer acetate injection. This is a generic drug that is used to treat multiple sclerosis, and it is expected to begin shipping…
